Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dinoprost tromethamine
Drug ID BADD_D00683
Description The tromethamine (THAM) salt of the naturally occurring prostaglandin F2 alpha, dinoprost tromethamine occurs as a white to off-white, very hygroscopic, crystalline powder. Dinoprost tromethamine may also be known as dinoprost trometamol, PGF2 alpha THAM, or prostaglandin F2 alpha tromethamine.
Indications and Usage Used for aborting second-trimester pregnancy (between the twelfth to eighteenth week of gestation) and in incomplete abortion or for therapeutic abortion in cases of intrauterine fetal death and congenital abnormalities incompatible with life. Also used at low-doses for medically indicated induction of labor at term. Also injected intra-arterially for use as a vasodilator to assist in angiography.
Marketing Status Discontinued
ATC Code G02AD01
DrugBank ID DB01160
KEGG ID D01352
MeSH ID C010714
PubChem ID 5282415
TTD Drug ID D04RGA
NDC Product Code 0009-5031; 69870-088
Synonyms dinoprost tromethamine | PGF2alpha tromethamine | prostaglandin F2alpha tromethamine | Lutalyse | Minprostin F2 Alpha | Prostin F2 | Prostin F2 Alpha
Chemical Information
Molecular Formula C24H45NO8
CAS Registry Number 38562-01-5
SMILES CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
MiosisVasopressin V1a receptorP37288T79232Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hyperventilation22.02.01.006; 19.01.02.004--Not Available
Hypokalaemia14.05.03.002--
Hypotension24.06.03.002--
Hypovolaemic shock24.06.02.017--Not Available
Ileus paralytic07.02.05.001--Not Available
Infection11.01.08.002--Not Available
Loss of consciousness17.02.04.004--Not Available
Malaise08.01.01.003--
Muscle spasms15.05.03.004--
Nausea07.01.07.001--
Pain08.01.08.004--
Paraesthesia17.02.06.005--
Petechiae24.07.06.004; 23.06.01.003; 01.01.03.002--Not Available
Polydipsia14.05.02.001; 05.03.03.002--Not Available
Pruritus23.03.12.001--
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Rash23.03.13.001--Not Available
Seizure17.12.03.001--
Shock24.06.02.002--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Tachycardia02.03.02.007--Not Available
Thrombophlebitis24.01.02.001--Not Available
Urinary incontinence20.02.02.010; 17.05.01.008--
Urinary tract infection11.01.14.004; 20.08.02.001--
Uterine atony21.07.03.001--Not Available
Uterine hypotonus21.07.03.005; 18.07.02.006--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages